| |
Treatment Modalities and Best Practice
The ultimate goals for treating ARF caused by sepsis are to eliminate the cause and to support the patient’s renal
function. The primary focus in treatment of prerenal disease is restoring the blood flow with adequate pressure to
the kidney. However, some of the treatments such as mechanical ventilation bring about further complications for
the renal system, requiring greater need for the following supportive measure: maintaining fluid and electrolyte
balance, removing nitrogenous wastes, sustaining nutrition, and providing emotional support and teaching to the
patient and his family.
Mechanical Ventilation
Renal blood flow (RBF) is decreased as a result of permissive hypercapnea, hypoxemia and positive end-expiratory
pressure (PEEP) associated with the use of mechanical ventilation. Decreased RBF caused by constriction in
permissive hypercapnea results from both direct and indirect mechanisms. According to Broden (2009), the direct
mechanism of hypercapnea is the stimulation of the sympathetic nervous system and release of norepinephrine,
causing vasoconstriction and decrease in renal blood flow and GFR. The indirect mechanism is the effect of systemic
vasodilatation and decrease vascular resistance, leading to further release of norepinephrine.
The use of lung-protective mechanical ventilation with optimal combination of lower tidal volumes and PEEP is
currently standard of practice for preventing acute lung injury. The use of PEEP has not been directly linked to
impairment of renal function. Healthcare providers need to recognize the stress of mechanical ventilation on the
renal system and conduct frequent ongoing thorough assessments to identify potential complications.
Fluid replacement and vasoactive drugs
Vasoactive medications are frequently used to increase the mean arterial pressure and blood flow to the kidneys
once the autoregulation of the kidneys is lost. Norepinephrine has been shown to be the most advantageous in
patients with acute kidney injury and failure caused by sepsis (Kosinski, 2009). The norepinephrine increases the
mean arterial pressure which, in turn, controls renal function and urine output. Norepinephrine has been shown to
decrease renal blood flow in hypovolemic patients; therefore, it is critical to treat hypovolemia with crystalloid
solutions prior to administration.
Dialysis
Acute renal failure can be treated by intermittent dialysis, peritoneal dialysis, or continuous renal replacement
therapy (CRRT). The treatment modality is determined based on the patient’s diagnosis and condition. Many patients
who are hemodynamically unstable do nottolerate intermittent dialysis as they often become hypotensive during
treatment. Repeated episodes of hypotension may cause further injury and ischemia to the nephrons. Likewise,
peritoneal dialysis is contraindicated in unstable patients because the pulmonary function may be compromised by
the large volume of fluid instilled into the peritoneal cavity. CRRT is tolerated best in unstable, critically ill
patients because it removes volume and solutes slowly, avoiding the rapid changes associated with hemodialysis. The
goals of CRRT are to maintain optimal fluid balance and to correct electrolyte and metabolic abnormalities.
Frequent assessments are required for patients who are on CRRT. Vital signs need to be monitored for hypotension
that may occur as a result of hypovolemia during therapy and for hypothermia that may occur as a result of the
amount of blood that is in the tubing outside the body. Perfusion and hemodynamic status should be assessed by
observing capillary refill, peripheral pulses, and skin temperature and color. The catheter site must be assessed
for warmth, redness, edema, drainage, and tenderness. Accurate monitoring of the patient’s electrolyte levels,
acid-base balance, and fluid balance are essential with CRRT. Hourly calculations must be performed to determine
adjustments in fluid volumes.
Caring for CRRT patients requires knowledge of the CRRT system for troubleshooting alarms when they occur. For
instance, if the patient is not receiving anticoagulant therapy and/or replacement fluids, the risk of clotting of
the hemofilter is increased.
Nutrition
Critically ill patients often experience catabolism due to stress, further contributing to increased risks of ARF.
The BUN and creatinine levels are increased as the body breaks down muscle for protein; however, nutrition should
be low in protein and sodium and high in fats and carbohydrates to prevent the protein burden on the patient’s
kidneys (Campbell, 2003). Fluids are generally restricted to the amount of the patient’s urine output plus 500 to
700 ml. Parental nutrition is recommended if the gastrointestinal tract is not functional.
|
|
|